Exogenously applied neurotrophic factors, growth factors, and other biological molecules improved axonal regeneration and other neurological functions in animal models of diabetes (5, 17, 18, 79); however, the translation of these molecules (e.g., NGF, BDNF, and VEGF) to humans has failed in clinical trials (80–82). The gene discussed is NGF; the disease is diabetes mellitus.